Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022121660> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2022121660 endingPage "40" @default.
- W2022121660 startingPage "33" @default.
- W2022121660 abstract "A total of 385 drug-therapy naïve patients, with inadequately controlled type 2 diabetes, were randomised into a multinational, parallel-group study to compare two strategies for dose titration of the oral hypoglycaemic agent repaglinide. Patients were allocated to either a fasting blood glucose (FBG) monitoring group with titration target 4.4-6.1 mmol/l or to a post-prandial blood glucose (PPBG) monitoring group with titration target 4.4-8.0 mmol/l. An initial titration period of up to 8 weeks was followed by a 12-week treatment period. Glycaemic control and hypoglycaemic outcomes were compared for the respective groups. HbA(1c) decreased significantly more in the FBG monitoring group by a mean of 1.38% compared to the PPBG group by a mean of 1.22% (P=0.03). The glycaemic control targets were met by fewer patients in the FBG group than in the PPBG group (57% versus 86% (P<0.001)) despite a higher mean dose of repaglinide in the FBG group. The within-patient blood glucose variability was significantly lower in the FBG group than in the PPBG group (P<0.001). In conclusion, repaglinide lowered the HbA(1c) effectively and safely in both groups and self-monitored FBG is a suitable parameter for titration of repaglinide. Whether a lower PPBG target might be as good a guide as FBG for titration of repaglinide should be addressed in a future study." @default.
- W2022121660 created "2016-06-24" @default.
- W2022121660 creator A5011164322 @default.
- W2022121660 creator A5011338575 @default.
- W2022121660 creator A5023352813 @default.
- W2022121660 creator A5034516594 @default.
- W2022121660 creator A5086230570 @default.
- W2022121660 date "2004-04-01" @default.
- W2022121660 modified "2023-10-17" @default.
- W2022121660 title "Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes" @default.
- W2022121660 cites W178039977 @default.
- W2022121660 cites W1964418709 @default.
- W2022121660 cites W1989089571 @default.
- W2022121660 cites W2020010218 @default.
- W2022121660 cites W2053670472 @default.
- W2022121660 cites W2077971957 @default.
- W2022121660 cites W2081805412 @default.
- W2022121660 cites W2084396445 @default.
- W2022121660 cites W2118629010 @default.
- W2022121660 cites W2132308332 @default.
- W2022121660 cites W2152759529 @default.
- W2022121660 cites W2158768965 @default.
- W2022121660 cites W2314314357 @default.
- W2022121660 cites W2337454357 @default.
- W2022121660 cites W2345903479 @default.
- W2022121660 cites W2470155809 @default.
- W2022121660 cites W2477199191 @default.
- W2022121660 doi "https://doi.org/10.1016/j.diabres.2003.10.006" @default.
- W2022121660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15036825" @default.
- W2022121660 hasPublicationYear "2004" @default.
- W2022121660 type Work @default.
- W2022121660 sameAs 2022121660 @default.
- W2022121660 citedByCount "4" @default.
- W2022121660 countsByYear W20221216602014 @default.
- W2022121660 crossrefType "journal-article" @default.
- W2022121660 hasAuthorship W2022121660A5011164322 @default.
- W2022121660 hasAuthorship W2022121660A5011338575 @default.
- W2022121660 hasAuthorship W2022121660A5023352813 @default.
- W2022121660 hasAuthorship W2022121660A5034516594 @default.
- W2022121660 hasAuthorship W2022121660A5086230570 @default.
- W2022121660 hasConcept C126322002 @default.
- W2022121660 hasConcept C134018914 @default.
- W2022121660 hasConcept C179104552 @default.
- W2022121660 hasConcept C184866935 @default.
- W2022121660 hasConcept C185592680 @default.
- W2022121660 hasConcept C2777180221 @default.
- W2022121660 hasConcept C2781281211 @default.
- W2022121660 hasConcept C555293320 @default.
- W2022121660 hasConcept C71924100 @default.
- W2022121660 hasConcept C90924648 @default.
- W2022121660 hasConceptScore W2022121660C126322002 @default.
- W2022121660 hasConceptScore W2022121660C134018914 @default.
- W2022121660 hasConceptScore W2022121660C179104552 @default.
- W2022121660 hasConceptScore W2022121660C184866935 @default.
- W2022121660 hasConceptScore W2022121660C185592680 @default.
- W2022121660 hasConceptScore W2022121660C2777180221 @default.
- W2022121660 hasConceptScore W2022121660C2781281211 @default.
- W2022121660 hasConceptScore W2022121660C555293320 @default.
- W2022121660 hasConceptScore W2022121660C71924100 @default.
- W2022121660 hasConceptScore W2022121660C90924648 @default.
- W2022121660 hasIssue "1" @default.
- W2022121660 hasLocation W20221216601 @default.
- W2022121660 hasLocation W20221216602 @default.
- W2022121660 hasOpenAccess W2022121660 @default.
- W2022121660 hasPrimaryLocation W20221216601 @default.
- W2022121660 hasRelatedWork W1563850031 @default.
- W2022121660 hasRelatedWork W2032287785 @default.
- W2022121660 hasRelatedWork W2059951325 @default.
- W2022121660 hasRelatedWork W2094113608 @default.
- W2022121660 hasRelatedWork W2233866314 @default.
- W2022121660 hasRelatedWork W2383009242 @default.
- W2022121660 hasRelatedWork W2415759662 @default.
- W2022121660 hasRelatedWork W3036934084 @default.
- W2022121660 hasRelatedWork W4233849132 @default.
- W2022121660 hasRelatedWork W4239196869 @default.
- W2022121660 hasVolume "64" @default.
- W2022121660 isParatext "false" @default.
- W2022121660 isRetracted "false" @default.
- W2022121660 magId "2022121660" @default.
- W2022121660 workType "article" @default.